左旋多巴治疗前后帕金森大鼠脑内&gamma;-氨基丁酸 A受体的变化

王晓巍; 崔宏福; 姚素艳; 刘建生; 郑德宇

doi:10.13418/j.issn.1001-165x.2015.06.013

中国临床解剖学杂志 ›› 2015, Vol. 33 ›› Issue (6) : 677-680. DOI: 10.13418/j.issn.1001-165x.2015.06.013

实验研究

左旋多巴治疗前后帕金森大鼠脑内γ-氨基丁酸 A受体的变化

王晓巍¹，　崔宏福¹，　姚素艳²，　刘建生¹，　郑德宇¹

作者信息 +

The change of gamma aminobutyric acid A receptor on Parkinsons rat before and after L-dopa treatment

WANG Xiao-wei¹，CUI Hong-fu¹，YAO Su-yan², LIU Jian-sheng¹, ZHENG De-yu¹

Author information +

文章历史 +

摘要

目的　探讨帕金森病治疗前后脑内皮质、黑质、纹状体部位γ-氨基丁酸A受体(gamma aminobutyric acid A receptor, GABAAR) 的分布变化规律。方法　首先制备PD大鼠模型，经检测成模后，随机分为对照组和治疗组，分别给予生理盐水和左旋多巴甲酯+苄丝肼治疗4周，治疗后经行为学检测，选择成功的治疗后的PD大鼠，于治疗后4、8、12周分别留取大鼠脑皮质、黑质和纹状体部位的标本，进行免疫组化检测，对比PD大鼠治疗前后脑内上述部位GABAAR的分布、表达情况变化。结果　治疗后 4、8、12周的免疫组化检测结果经统计学分析，脑内黑质和皮质部位的GABAAR阳性表达的细胞治疗后比治疗前减少。而纹状体部位的GABAAR阳性表达的细胞数量无明显变化。结论　(1)左旋多巴甲酯+苄丝肼治疗PD大鼠，可以使症状改善。(2)PD大鼠治疗前后脑内不同部位GABAAR的变化不同。

Abstract

Objective　To investigate varying pattern of distribution of gamma aminobutyric acid A receptor (GABAAR) before and after treatment in the brain cortex, striatum, substantianigra on Parkinson's disease. Methodes　First, the rat model of PD was made, after testing, were randomly divided into treatment group and control group. They were given normal saline and L-dopa methyl ester + Benserazide for 4 weeks. After treatment the behavioral tests were performed. Cerebral cortex, striatum, substantianigra were harvested from rats after treatment of 4, 8, 12 weeks respectively. By immunohistochemistry, the changes in distribution and expression of content of GABAAR in the brain were compared before and after treatment.　Results　After treatment of 4, 8, 12 weeks immunohistochemical results was subjected through statistical analysis, which showed the content of the brain substantianigra and cortex GABAAR was decreased than before treatment, While the number of striatum showed no changes of GABAAR.　Conclusion　(1) With treatment of L-dopa methyl ester + Benserazide, the PD symptoms can be improve. (2) The changes of GABAAR are different on different parts of PD rats before and after treatment.

导出引用

王晓巍,崔宏福,姚素艳,刘建生,郑德宇. 左旋多巴治疗前后帕金森大鼠脑内γ-氨基丁酸 A受体的变化[J]. 中国临床解剖学杂志. 2015, 33(6): 677-680 https://doi.org/10.13418/j.issn.1001-165x.2015.06.013

The change of gamma aminobutyric acid A receptor on Parkinsons rat before and after L-dopa treatment[J]. Chinese Journal of Clinical Anatomy. 2015, 33(6): 677-680 https://doi.org/10.13418/j.issn.1001-165x.2015.06.013

参考文献

[1] 李小茜，何建成. γ-氨基丁酸与帕金森病、左旋多巴诱发异动症的研究进展[J].医学研究杂志，2013，42（3）:6-8.
[2] 郭燕舞，李明，张世忠. γ-氨基丁酸治疗帕金森病的研究展望［J］.实用医学杂志，2009，25（18）：2991-2993.
[3] 包新民，舒斯云. 大鼠脑立体定位图谱[M]. 北京；人民卫生出版社，1991，12（1）：48-54.
[4] 孟涛，林玲，郑志竑,等.大鼠胚胎中脑腹侧细胞和大脑皮质神经干细胞移植治疗帕金森大鼠的比较[J].神经解剖学杂志，2009，25(5):493-496.
[5] Mochizuki H， Yasuda T， Mouradian MM． Advances in gene therapy for movement disorders [J]. Neurotherapeutics， 2008，5（2）：260-269．
[6] 郭文，王丽.氯巴占耐受听源性惊厥大鼠脑GABAA受体亚单位表达的变化[J]．中国药理学通报，2002,18(2)：183-186.